Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/11/2017
CFDA Solicits Public Comments on Naming Principle of Formulated TCMs
1/11/2017
Demographic Convergence And The Coming Chinese Healthcare Explosion
1/11/2017
Chi-Med Initiates HMPL-523 Clinical Trials in Hematological Cancer in ...
1/11/2017
MilliporeSigma Expands Biodevelopment Centers to the U.S. and China
1/11/2017
USTR Releases 2016 Report on China's WTO Compliance Highlighting Pharm...
1/10/2017
U.S. DEA Opens China Office to Help Fight Synthetic Drug Trade
1/10/2017
Kite and Fosun Form Chinese JV for Autologous T-Cell Therapies to Trea...
1/10/2017
Data Snapshot - Review of Chinese Drug Registration Applications 2010-...
1/10/2017
State Council Issues China's 13th Five Year Plan for Healthcare Reform
1/10/2017
CDE Seeks Public Comments on Proposed Guideline for Chemical Drug Manu...
1/9/2017
AbbVie, Genomics Medicine and WuXi NextCODE Announce Landmark Populati...
1/9/2017
BeiGene Announces First Patient Dosing in China Phase I Trial for Anti...
1/9/2017
Valeant To Sell Dendreon To Sanpower Group for $819.9M in Cash
1/9/2017
China’s Cancer Patients Gamble on Gray Market
1/9/2017
Fosun Pharma Unveils Plan to Offer Innovative Options for Battle again...
1/9/2017
NHFPC Lays Out Major Tasks for 2017 at National Health Conference
1/9/2017
China Introduces Implementation Rule for "Two Invoice System"...
1/6/2017
CFDA Announces Overview of Drug Applications under MAH Trial
1/6/2017
Jiangsu Nhwa Pharma Licenses China Rights of NVX-408 from NuvOx Pharma
1/6/2017
Ambrx and MabSpace Biosciences to Collaborate on Novel Antibody Drug C...
1/5/2017
TOT Biopharm and Lee's Pharma Enters Licensing Agreement on mAb Drug T...
1/5/2017
Drug Kickbacks, the Incurable Disease of Public Hospitals in China
1/5/2017
Big Data Policy And Legal Issues In The Healthcare Industry
1/5/2017
PhIRDA Joins IFPMA as A Formal Member
1/4/2017
US FDA Grants Orphan Drug Designation to Yisheng Biopharma's PIKA Rabi...
1/4/2017
CFDA Announces Latest Clinical Data Inspection Plan
1/4/2017
Updated - Shanghai to Partially Reimburse 24 Expensive Drug Products, ...
1/4/2017
CFDA Offer Interpretations on the Ongoing MAH Trial
1/4/2017
Frontier Biotech Raises CNY 300M in Series C Financing Round
1/3/2017
Data Snapshot: Chinese Anti-hypertensive Chemical Drug Market 2013-201...
Page:
378
/
777
Total number of articles:
23289
:
[First]
[<<]
[376]
[377]
[378]
[379]
[380]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit